Advancing Clarivate strategy to extend proprietary intelligence into enterprise AI ecosystems Bringing Clarivate domain-specific regulatory insights into Claude to support life sciences workflows Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced they will integrate Clarivate’s proprietary regulatory intelligence with Claude’s AI reasoning capabilities. The collaboration gives biopharma, biotech, medtech and clinical research










